🔗 Visit the ClinicalTrials.gov page for NCT00878423
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers. | Biochim Biophys Acta | 2011 | 2.21 |
| 2 | A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation. | Mol Cancer | 2013 | 0.90 |
| 3 | Heat shock protein 90 inhibition: rationale and clinical potential. | Ther Adv Med Oncol | 2012 | 0.82 |
| 4 | Biomarkers as key contributors in treating malignant melanoma metastases. | Dermatol Res Pract | 2011 | 0.79 |